archives : September 2007

     

South africa - Caribbean islands - United States - International

News that one of the most promising and advanced HIV vaccine trials has been halted has dealt a serious blow to global AIDS prevention efforts.

The vaccine’s developer, Merck, announced that it was ending enrollment and vaccination of volunteers in the US National Institutes of Health-funded study following a lack of evidence the vaccine had lowered the risk of HIV infection or reduced the severity of infection among volunteers who became infected during the trial.

- Monday 24 September 2007

August 2007 archives October 2007 archives



 


last articles

search
 

newsletter